跳至主要内容
临床试验/ITMCTR2100004292
ITMCTR2100004292招募中1 期

The clinical application of thunder-fire moxibustion to breast cancer chemotherapy-induced nausea and vomiting

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
Female

入选标准

  • (1) Patients are informed, agree and sign the Informed Consent, voluntarily participate in this observation study, comply with the researcher's needs, promise to accept the treatment and safety observation, and facilitate follow-up.
  • (2) For females, the youngest is 18 years old and the oldest is 75 years old.
  • (3) Breast cancer diagnosed after pathological examination.
  • (4) Patients who have completed at least 3 chemotherapy cycles.
  • (5) Pre-chemotherapy evaluation card score is greater than or equal to 60.
  • (6) Breast cancer patients who received EC (cyclophosphamide + epirubicin) hyperemetic chemotherapy.
  • (7) Blood images, liver and kidney functions before chemotherapy were in the normal range, meeting the basic indications and requirements of chemotherapy.
  • (8) Lucid, no serious hearing impairment, a certain degree of comprehension and language skills.

排除标准

  • (1) Language barrier preventing sufficient communication ability.
  • (2) Nausea or vomiting within 24 hours before chemotherapy.
  • (3) Patients with severe or uncontrolled organic lesions or infections, such as decompensated heart, liver, lung, or renal failure.
  • (4) Persons suffering from uncontrollable mental illness or mental disorder
  • (5) Patients with obstruction of the digestive tract.
  • (6) Metastasized breast cancer.
  • (7) Pregnant and lactating women.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验